Skip to main content
Clinical Trials/IRCT20240406061424N1
IRCT20240406061424N1
Completed
Phase 3

Randomized controlled trial of the effect of oral Conjugated Estrogen on the bleeding complications after renal needle biopsy sampling in patients with insufficiency in Namazi hospital during 2022

Shiraz University of Medical Sciences0 sites32 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
?????? ????.
Sponsor
Shiraz University of Medical Sciences
Enrollment
32
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Men and women from 18 to 80 years
  • 1\.5\= serum Creatinin or GFR\=60ml/min
  • Blood pressure less than 140/90 mmhg
  • Platelet count within normal range

Exclusion Criteria

  • Patients with uncontrolled blood pressure
  • Patients with one kidney
  • Patients with small kidneys
  • In case of hydronephrosis or pyonephrosis
  • If there is kidney cancer
  • Patients with active urinary tract infection
  • Patients with coagulation disorders
  • Patients with severe obesity
  • Patients with Cr\<1\.5 mg/dl or GFR\>60ml/min

Outcomes

Primary Outcomes

Not specified

Similar Trials